Welcome to our dedicated page for Elevance Health news (Ticker: ELV), a resource for investors and traders seeking the latest updates and insights on Elevance Health stock.
Elevance Health, Inc. (NYSE: ELV) generates a steady stream of news as a major participant in the direct health and medical insurance carriers industry. Company updates frequently focus on financial performance, member experience initiatives, digital tools, and community health programs. Investors and observers following ELV news can see how Elevance Health communicates its strategy as a lifetime, trusted health partner serving over 109 million consumers through medical, pharmacy, behavioral, clinical, home health, and complex care solutions.
News coverage often includes earnings results and guidance, such as quarterly financial releases that detail segment performance for Health Benefits and Carelon, membership trends across commercial, Medicare, Medicaid, and Federal Employee Program lines, and commentary on benefit expense ratios and operating metrics. The company also issues announcements about upcoming conference calls and webcasts where management reviews results and outlook with investors.
Another key theme in Elevance Health news is the evolution of the healthcare consumer experience. Articles describe AI-enabled digital solutions, including the Virtual Assistant available through the Sydney Health app, which helps members understand benefits, compare costs, and find in-network providers. The company also highlights care management programs, concierge-style support for serious illnesses, and models such as “My Health Advocate” in affiliated Medicare plans.
Elevance Health news frequently covers whole-health and community initiatives. Examples include Food as Medicine partnerships with the National Association of Community Health Centers, school-based fitness facility upgrades, and expanded access to doula care and social supports in certain Medicare Advantage and Medicaid plans. Governance developments, such as the appointment of independent directors to the board and related committee assignments, are also reported through press releases and SEC-linked announcements.
By reviewing the ELV news feed on this page, readers can follow financial disclosures, strategic initiatives, digital and clinical innovations, and community-focused programs that shape Elevance Health’s role in the health benefits and healthcare services landscape.
Elevance Health reported strong third quarter 2022 results with a GAAP net income of $6.68 per share, adjusted net income at $7.53 per share, and operating revenue of $39.6 billion, up 11.5% year-over-year. Medical enrollment increased by 2.2 million to 47.3 million members. The company also declared a fourth quarter dividend of $1.28 per share. With a projected full-year GAAP net income exceeding $25.33 per share, Elevance demonstrates robust growth driven by strategic operations and increasing membership.
Elevance Health announced its affiliated health plans will offer $0 premium Medicare Advantage plans targeting nearly 33 million Medicare-eligible individuals. With inflation impacting costs, three-quarters of their plans for 2023 feature zero premiums and no co-pays for primary care visits. A new prepaid benefits card simplifies access to various benefits. Additionally, eligible consumers can receive grocery card benefits and access to dietitians. The plans will expand to serve 2.1 million new Medicare-eligible consumers across 145 counties, bolstering Elevance Health's presence in the Medicare market.
Elevance Health has announced that its affiliated Medicare Advantage plans received an overall 4 out of 5 Star rating from the Centers for Medicare & Medicaid Services (CMS) for 2023. Notably, 64% of beneficiaries will enroll in plans rated 4 Stars or higher. Some plans, including HealthSun Health Plans and Optimum Healthcare, achieved the maximum 5 Star rating for multiple years. This success is attributed to improved consumer experiences and a focus on digital innovations aimed at enhancing health outcomes.
Elevance Health (NYSE: ELV) will announce its third-quarter 2022 financial results on October 19, 2022, at 6:00 a.m. EDT. A conference call will follow at 8:30 a.m. EDT, accessible by dialing the provided numbers. The access code for the call is 3972058. A replay will be available from 11:30 a.m. EDT on the same day until November 18, 2022. Elevance Health serves over 118 million consumers with a diverse range of health solutions, aiming to enhance human health.
Elevance Health announces substantial financial support for recovery efforts in the wake of Hurricane Ian. The company is donating a total of $2.7 million to various disaster relief organizations to assist Florida and other affected communities. Key contributions include $1 million each to the Florida Disaster Relief fund and the American Red Cross, along with additional funding to Americares, Direct Relief, and Rebuilding Together. These initiatives aim to provide critical medical supplies and support to over 1 million members of affiliated health plans.
Zylorion Health Inc. has announced the appointments of Jeroen Tas to its Board of Directors and Ted Goldstein to its Digital Health Advisory Committee. Tas, former Chief Innovation and Strategy Officer at Philips, and Goldstein, ex-Chief Artificial Intelligence Officer at Elevance Health, bring extensive experience in health technologies and bioinformatics. CEO Peter Silverstone expressed enthusiasm over their addition, highlighting their potential contributions to Zylorion's mission of delivering innovative therapies for mental health challenges, including MDD, TRD, and PTSD.
Elevance Health (NYSE: ELV) announced a partnership with Aledade to enhance consumer experiences and health outcomes in independent primary care. This collaboration aims to assist these providers in transitioning to value-based care, improving patient outcomes and reducing costs. With access to Aledade’s technology and support services, independent practices can strengthen their operations while serving 47 million members in Elevance's networks. The initiative is positioned to empower physicians and enrich primary care across communities.
New research by the Urban Institute, American Benefits Council, and Deloitte's Health Equity Institute, funded by Elevance Health, highlights the importance of high-quality race and ethnicity data in addressing health disparities. The report identifies challenges related to inconsistent data, which hinders the tracking of health inequities. Key recommendations include enhancing community engagement, ensuring data privacy, and modernizing data collection practices to promote health equity. The COVID-19 pandemic has intensified the urgency for comprehensive data to tailor care for marginalized communities.
Elevance Health, Inc. (NYSE: ELV) reported impressive second-quarter 2022 results with a GAAP net income of $6.79 per share, adjusted to $8.04, reflecting a 14.4% year-over-year increase. Operating revenue rose 15.6% to $38.5 billion, bolstered by a 2.7 million increase in medical enrollment, totaling 47.1 million members. The company declared a third-quarter dividend of $1.28 per share. With strong performance across segments, Elevance raised its 2022 earnings outlook to expect GAAP net income exceeding $25.28 per share.
Elevance Health (NYSE: ELV) will announce its second quarter 2022 financial results on July 20, 2022, at 6:00 a.m. EDT. A conference call to discuss these results and the company's outlook will follow at 8:30 a.m. EDT. Investors can join the call via various numbers or through a live webcast on www.elevancehealth.com. The call replay will be available from 11:30 a.m. EDT on July 20 until August 20, 2022.
Elevance Health serves over 118 million individuals with comprehensive care solutions.